Optimizing Patient Outcomes in Chronic Myeloid Leukemia Through the Use of Tyrosine Kinase Inhibitors
This activity will focus on the role of the pharmacist in using guideline recommendations for treating CML.
Assessing Effective Treatment Options for Bladder Cancer: Examining Current and Emerging Therapies
This activity will examine the important role of pharmacists and managed care professionals when assessing therapies and potential sequencing options for patients with bladder cancer to achieve optimal outcomes and increase progression-free survival.
The Evolving Treatment Landscape for ALK-Positive Metastatic Non-Small Cell Lung Cancer: Supportive Care Considerations for Specialty Pharmacists
This activity will review the optimal place in therapy for ALK inhibitors while emphasizing the role of the pharmacist in caring for this patient population.
Optimizing the Value of CAR T-Cell Therapy: Managed Care Considerations From Recent Clinical Findings
Explore the rationale for CAR T-cell therapy in hematologic malignancies.